跳至主要内容
临床试验/CTRI/2024/11/077021
CTRI/2024/11/077021已完成不适用

A study to evaluate effect of consumption of food products on Glycemic index in healthy human volunteers

Amway Global Services India Pvt Ltd1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2024年11月28日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14
试验地点
1
主要终点
To assess glycemic index using blood sugar

研究概览

简要总结

The glycemic index (GI) is a measure of the blood glucose-raising potential

of the Carbohydrate content of a food compared to a reference food

(generally pure glucose) (https://lpi.oregonstate.edu/mic/food-beverages/gl

ycemic-index-glycemic-load). It is measured in a scale of 0-100 where

below 55 is considered as low glycemic index, 56- 69 as medium glycemic

index and 70 and above as high glycemic index. Foods that have refined

sugar contents have generally more glycemic index and might affect the

blood sugar levels whereas foods with typically less sugar and more fibre

have less glycemic index.

Subjects who fulfil the eligibility criteria will be enrolled in the study after

signing the informed consent form.

Present study is aimed to evaluate the glycemic index of Six food

products by Amway. This will be a single blind, repeated, cross over study

in 14 subjects

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • 1.Healthy adults (based on medical history and screening tests) in the age group of 18 and 45 years – male and female (1:1 ratio) 2.Fasting blood glucose levels more than 100mg/dL.
  • 3.BMI should be between 18.5 to 23 kg/m2 4.Lipid profile (Total cholesterol) within normal range as applicable 5.Agree to participate in the study 6.Able and willing to follow all study related instructions.
  • 7.Must be willing to give written informed consent and comply with the study procedures.
  • 8.Subject’s complete blood count parameters to be within clinically acceptable range by Investigator.

排除标准

  • 1.Subjects with BMI less than 18.5kg/m2 or more than 23 kg/m2 will be excluded from the study.
  • 2.Total cholesterol higher than normal range.
  • 3.Subjects particularly on any special diet 4.Subjects suffering from any systemic disorders (diabetes, cardiovascular, renal, pulmonary, endocrine, or neurological disorders, ulcers, dermatologic disorders, autoimmune diseases) or severe food allergies; an active infectious disease (HBV, HCV, HIV)
  • current diagnosis or a history of relevant depressive episodes or of panic attacks, psychosis, bipolar or eating disorders 6.Pregnant or lactating women 7.Patient having participated in any other clinical trial within one month prior to screening.

结局指标

主要结局

To assess glycemic index using blood sugar

时间窗: Assessment of blood glucose levels at -5, 15, 30, 45, 60 90 and 120 minutes

levels measured at fixed intervals

时间窗: Assessment of blood glucose levels at -5, 15, 30, 45, 60 90 and 120 minutes

次要结局

  • To assess change in hematological and(biochemical parameters from baseline to end of)

研究者

发起方
Amway Global Services India Pvt Ltd
申办方类型
Pharmaceutical industry-Global
责任方
Principal Investigator
主要研究者

Dr Madhusudan C

NRR Hospital

研究点 (1)

Loading locations...

相似试验